FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients age ≥60 years.
Shai ShimonyGeoffrey G FellEvan C ChenHarrison K TsaiMartha WadleighEric S WinerJacqueline S GarciaMarlise R LuskinMaximilian StahlDonna S NeubergDaniel J DeAngeloR Coleman LindsleyRichard M StonePublished in: Blood advances (2023)